))
The Lancet Gastroenterology & Hepatology is a monthly journal that considers original research, reviews, and personal views in gastroenterology and hepatology from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.
L
Listen to The Lancet Gastroenterology & Hepatology
1
Colorectal cancer risk in patients with Crohn’s disease
7:04
7:04
Play later
Play later
Lists
Like
Liked
7:04
By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Anti-TNFα therapy and risk of cancer in patients with immune-mediated diseases
4:08
4:08
Play later
Play later
Lists
Like
Liked
4:08
By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Eosinophilic oesophagitis endotype classification
10:17
10:17
Play later
Play later
Lists
Like
Liked
10:17
Marc Rothenberg joins The Lancet Gastroenterology & Hepatology to talk about eosinophilic oesophagitis endotype classification.By The Lancet
By The Lancet
By The Lancet
By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Global burden of pancreatic cancer and colorectal cancer
14:44
14:44
Play later
Play later
Lists
Like
Liked
14:44
By The Lancet
By The Lancet
By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Primary anastomosis as a treatment for diverticulitis
8:29
8:29
Play later
Play later
Lists
Like
Liked
8:29
Daniel Lambrichts joins The Lancet Gastroenterology & Hepatology to discuss different treatments for diverticulitis.By The Lancet
By The Lancet
By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Viral hepatitis in children & adolescents
24:54
24:54
Play later
Play later
Lists
Like
Liked
24:54
By The Lancet
By The Lancet
Dr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome.By The Lancet
Bart Rijnders discusses his recent work on the treatment of people with acute hepatitis C.By The Lancet
Jennifer Flemming talks with The Lancet Gastroenterology & Hepatology about recent developments in the field of chronic liver disease.By The Lancet
Graham Foster speaks with The Lancet Gastroenterology & Hepatology about his recent work on incentivising and supporting primary-care physicians to increase hepatitis screenings of migrant populations.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
DAA treatment for hepatitis C among people who inject drugs
11:12
11:12
Play later
Play later
Lists
Like
Liked
11:12
Behzad Hajarizadeh joins The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs.By The Lancet
Michele Reni speaks with The Lancet Gastroenterology & Hepatology about the PAXG regimen for treatment of pancreatic cancer.By The Lancet
Marco Carbone talks to The Lancet Gastroenterology & Hepatology about predicting treatment response for patients with primary biliary cholangitisBy The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Global prevalence, treatment, and prevention of hepatitis B virus infection
13:37
13:37
Play later
Play later
Lists
Like
Liked
13:37
Homie Razavi and Devin Razavi-Shearer join The Lancet Gastroenterology & Hepatology to discuss their HBV modelling study.By The Lancet
Jasper Vleugels joins The Lancet Gastroenterology and Hepatology to discuss the results of the FIND-UC trial.By The Lancet
Imran Aziz discusses his paper on functional dyspepsia, which is published in the April issue of The Lancet Gastroenterology & Hepatology.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Can DAA therapy for HCV reactivate HBV in coinfected patients?
9:10
9:10
Play later
Play later
Lists
Like
Liked
9:10
In this Lancet Gastroenterology & Hepatology podcast, Johannes Vermehren discusses the risks of Hepatitis B reactivation in coinfected patients receiving treatment for Hepatitis C.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Oral immunotherapy: The Lancet Gastroenterology & Hepatology: February 2018
19:00
19:00
Play later
Play later
Lists
Like
Liked
19:00
Sandra Andorf and Kari Nadeau discuss their work on anti-IgE treatment with oral immunotherapy in multifood allergic participants.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Faecal transplantation: The Lancet Gastroenterology & Hepatology: Jan 2018
7:17
7:17
Play later
Play later
Lists
Like
Liked
7:17
Peter Johnsen discusses his paper on faecal transplantation as a treatment for IBS.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
PROTECT study: The Lancet Gastroenterology & Hepatology: December 2017
12:53
12:53
Play later
Play later
Lists
Like
Liked
12:53
Jeffrey Hyams discusses the PROTECT study, which looks at outcomes in paediatric ulcerative colitis.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Research priorities in Barrett's and GORD: The Lancet Gastroenterology & Hepatology: August 31, 2017
21:50
21:50
Play later
Play later
Lists
Like
Liked
21:50
Yeng Ang and James Britton discuss setting research priorities for future work in Barrett's oesophagus and gastro-oesophageal reflux diseaseBy The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Neurostimulation for abdominal pain: The Lancet Gastroenterology & Hepatology: August 18, 2017
10:28
10:28
Play later
Play later
Lists
Like
Liked
10:28
Adrian Miranda talks about his work on using neurostimulation as a method for addressing abdominal pain-related functional gastrointestinal disorders in children.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Oesophageal motility and solid meal tests: The Lancet Gastroenterology & Hepatology: August 2, 2017
10:26
10:26
Play later
Play later
Lists
Like
Liked
10:26
Mark Fox talks about development of a solid meal test for diagnosing oesophageal motility disorders.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
HALT-HCC score: The Lancet Gastroenterology & Hepatology: July 5, 2017
7:26
7:26
Play later
Play later
Lists
Like
Liked
7:26
Federico Aucejo talks about his HALT-HCC score, which assesses risk for patients with hepatocellular carcinoma awaiting liver transplant.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Early intervention for alcohol-related liver disease: The Lancet Gastroenterology and Hepatology: June 7, 2017
13:40
13:40
Play later
Play later
Lists
Like
Liked
13:40
Nick Sheron covers the public health and clinical problems presented by alcohol-related liver disease, and discusses what can be achieved with early intervention.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Stem cell transplantation in Crohn's: The Lancet Gastroenterology & Hepatology: May 5, 2017
12:57
12:57
Play later
Play later
Lists
Like
Liked
12:57
James Lindsay discusses his article on autologous stem-cell transplantation in treatment-refractory Crohn's disease.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Colorectal cancer in sub-Saharan Africa: The Lancet Gastroenterology & Hepatology: April 5, 2017
7:00
7:00
Play later
Play later
Lists
Like
Liked
7:00
Leo Katsidzira talks about the epidemiology of colorectal cancer in sub-Saharan Africa.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Treatment of an appendix mass in children: The Lancet Gastroenterology & Hepatology: March 8, 2017
8:46
8:46
Play later
Play later
Lists
Like
Liked
8:46
As part of The Lancet Gastroenterology & Hepatology’s April issue, Nigel Hall discusses the CHINA trial of observation versus interval appendicectomy for children with an appendix mass.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Treatment and reinfection risk for hepatitis C treatment: The Lancet Gastroenterology & Hepatology: February 8, 2017
12:11
12:11
Play later
Play later
Lists
Like
Liked
12:11
Naveed Janjua discusses a study looking at the risk factors associated with hepatitis C reinfection and means to prevent it.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Irritable bowel syndrome: The Lancet Gastroenterology & Hepatology: Feb 2017
11:47
11:47
Play later
Play later
Lists
Like
Liked
11:47
Magnus Simrén comprehensively reviews treatments and therapies for irritable bowel syndrome.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Barrett's oesophagus: The Lancet Gastroenterology & Hepatology: Jan 2017
12:56
12:56
Play later
Play later
Lists
Like
Liked
12:56
Rebecca Fitzgerald discusses her paper on risk stratification for patients with Barrett's oesophagus.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Inflammatory bowel disease: The Lancet Gastroenterology & Hepatology: December issue
16:18
16:18
Play later
Play later
Lists
Like
Liked
16:18
Gil Kaplan discusses the rise of IBD in countries that don't have a history of the disease.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Liver fibrosis screening: The Lancet Gastroenterology & Hepatology: October 12, 2016
10:41
10:41
Play later
Play later
Lists
Like
Liked
10:41
Pere Ginès from the Liver Unit at the Hospital Clinic in Barcelona, Spain, discusses a Viewpoint for liver fibrosis screening in the general population.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Migraine and GI disorders: The Lancet Gastroenterology & Hepatology: September 7, 2016
7:36
7:36
Play later
Play later
Lists
Like
Liked
7:36
Luigi Titomanlio from INSERM in France discusses a case control study investigating an association between functional gastrointestinal disorders and migraine.By The Lancet
L
Listen to The Lancet Gastroenterology & Hepatology
1
Reducing population alcohol consumption: The Lancet Gastroenterology & Hepatology: August 10, 2016
19:00
19:00
Play later
Play later
Lists
Like
Liked
19:00
In the first podcast for The Lancet Gastroenterology & Hepatology, Editor Rob Brierley outlines the scope of the new journal, and Jürgen Rehm discusses public health priorities for reducing population alcohol consumption.By The Lancet
